| scholarly article | Q13442814 |
| P50 | author | Jérome Ezan | Q47438908 |
| P2093 | author name string | Pierre Costet | |
| Cécile Duplàa | |||
| Laurent Barandon | |||
| Pascale Dufourcq | |||
| Philippe Alzieu | |||
| Thierry Couffinhal | |||
| Lionel Leroux | |||
| Catherine Moreau | |||
| Danièle Dare | |||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 2282-2289 | |
| P577 | publication date | 2003-10-27 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA. | |
| P478 | volume | 108 |
| Q34044380 | Active Wnt signaling in response to cardiac injury |
| Q42424052 | Adjustment and Characterization of an Original Model of Chronic Ischemic Heart Failure in Pig |
| Q47137916 | Apoptosis inhibitor of macrophage depletion decreased M1 macrophage accumulation and the incidence of cardiac rupture after myocardial infarction in mice |
| Q37619658 | Association of genetic variations in the Wnt signaling pathway genes with myocardial infarction susceptibility in Chinese Han population |
| Q36868287 | Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels |
| Q37018900 | Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. |
| Q28258964 | Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts |
| Q38215191 | Building and repairing the heart: what can we learn from embryonic development? |
| Q38846401 | Can heart function lost to disease be regenerated by therapeutic targeting of cardiac scar tissue? |
| Q26862552 | Cardiac side population cells: moving toward the center stage in cardiac regeneration |
| Q37707161 | Cell-cell interaction in the heart via Wnt/β-catenin pathway after cardiac injury |
| Q28510953 | Chibby, an antagonist of the Wnt/beta-catenin pathway, facilitates cardiomyocyte differentiation of murine embryonic stem cells |
| Q55496723 | Circulating levels of sclerostin are associated with cardiovascular mortality. |
| Q39485853 | Continuous antagonism by Dkk1 counter activates canonical Wnt signaling and promotes cardiomyocyte differentiation of embryonic stem cells |
| Q51204061 | Decreased WNT/β-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene. |
| Q33749358 | Diabetes mellitus: channeling care through cellular discovery |
| Q36266464 | Excess placental secreted frizzled-related protein 1 in maternal smokers impairs fetal growth |
| Q36000159 | Exogenous high-mobility group box 1 protein injection improves cardiac function after myocardial infarction: involvement of Wnt signaling activation |
| Q42775592 | Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition |
| Q38184790 | Fibroblast-mediated pathways in cardiac hypertrophy |
| Q37090676 | Fibrosis of the Neonatal Mouse Heart After Cryoinjury Is Accompanied by Wnt Signaling Activation and Epicardial-to-Mesenchymal Transition |
| Q41475488 | FrzA gene protects cardiomyocytes from H2O2-induced oxidative stress through restraining the Wnt/Frizzled pathway |
| Q51891379 | GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways. |
| Q64988590 | GSK3β inhibition and canonical Wnt signaling in mice hearts after myocardial ischemic damage. |
| Q37470623 | Gene and cell therapy for heart failure |
| Q92316784 | Genome-Wide Association Study of Metabolic Syndrome Reveals Primary Genetic Variants at CETP Locus in Indians |
| Q91657126 | High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention |
| Q37998444 | Importance of myocyte-nonmyocyte interactions in cardiac development and disease |
| Q24336816 | Increased expression of secreted frizzled-related protein 4 in polycystic kidneys |
| Q36819462 | Inhibition of Wnt6 by Sfrp2 regulates adult cardiac progenitor cell differentiation by differential modulation of Wnt pathways |
| Q30431643 | Inhibition of canonical Wnt signaling increases microvascular hemorrhaging and venular remodeling in adult rats |
| Q38042490 | Interventions in Wnt signaling as a novel therapeutic approach to improve myocardial infarct healing |
| Q41101732 | Loss of Macrophage Wnt Secretion Improves Remodeling and Function After Myocardial Infarction in Mice |
| Q35721399 | Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction |
| Q39859295 | Loss of secreted frizzled-related protein-1 leads to deterioration of cardiac function in mice and plays a role in human cardiomyopathy. |
| Q30277999 | Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation |
| Q35067279 | Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolism, and enhanced macrophage infiltration |
| Q36885445 | Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems |
| Q37946338 | Nestin+ cells and healing the infarcted heart |
| Q34552287 | Novel avenues of drug discovery and biomarkers for diabetes mellitus |
| Q35879163 | Overexpression of angiopoietin-2 impairs myocardial angiogenesis and exacerbates cardiac fibrosis in the diabetic db/db mouse model |
| Q28085424 | Physiological Implications of Myocardial Scar Structure |
| Q37845920 | Physiological inhibitors of Wnt signaling |
| Q40714188 | Porphyromonas gingivalis, a periodontal pathogen, enhances myocardial vulnerability, thereby promoting post-infarct cardiac rupture |
| Q33885315 | Regulation of early growth response 2 expression by secreted frizzled related protein 1 |
| Q24304483 | Regulation of endothelial cell cytoskeletal reorganization by a secreted frizzled-related protein-1 and frizzled 4- and frizzled 7-dependent pathway: role in neovessel formation |
| Q89736925 | Role of Sfrps in cardiovascular disease |
| Q38064702 | Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential. |
| Q35750462 | Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). |
| Q28508856 | Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction |
| Q38780532 | Secreted frizzled related protein 1 protects H9C2 cells from hypoxia/re-oxygenation injury by blocking the Wnt signaling pathway |
| Q28587325 | Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair |
| Q37260268 | Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a |
| Q92750770 | Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease |
| Q89427974 | Temporary, Systemic Inhibition of the WNT/β-Catenin Pathway promotes Regenerative Cardiac Repair following Myocardial Infarct |
| Q50333784 | The Biological Role of Nestin(+)-Cells in Physiological and Pathological Cardiovascular Remodeling |
| Q36728844 | The Wnt signaling pathway: aging gracefully as a protectionist? |
| Q37882050 | The Wnt/Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand? |
| Q47787830 | The canonical way to make a heart: β-catenin and plakoglobin in heart development and remodeling. |
| Q56974209 | The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure |
| Q55082769 | The contribution of Islet1-expressing splanchnic mesoderm cells to distinct branchiomeric muscles reveals significant heterogeneity in head muscle development. |
| Q37035383 | The functions and possible significance of Kremen as the gatekeeper of Wnt signalling in development and pathology |
| Q36863354 | The role of Wnt regulation in heart development, cardiac repair and disease: A tissue engineering perspective |
| Q34999427 | The small molecule Wnt signaling modulator ICG-001 improves contractile function in chronically infarcted rat myocardium |
| Q37168629 | Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection |
| Q41892971 | Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia |
| Q37331189 | Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure. |
| Q55238585 | Transient fibrosis resolves via fibroblast inactivation in the regenerating zebrafish heart. |
| Q36727444 | Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus |
| Q40212341 | Upregulation of frizzled 9 in astrocytomas. |
| Q26770160 | View from the heart: cardiac fibroblasts in development, scarring and regeneration |
| Q47299786 | WNT Signaling in Cardiac and Vascular Disease. |
| Q92422653 | WNT Signaling in Disease |
| Q29616159 | WNT and beta-catenin signalling: diseases and therapies |
| Q30278655 | Why Is Infarct Expansion Such an Elusive Therapeutic Target? |
| Q36305544 | Winding through the WNT pathway during cellular development and demise |
| Q38542451 | Wnt Signaling in Cardiac Disease |
| Q52815224 | Wnt Signaling in Cardiac Remodeling and Heart Failure. |
| Q47280595 | Wnt inhibition promotes vascular specification of embryonic cardiac progenitors |
| Q36702732 | Wnt signaling and human diseases: what are the therapeutic implications? |
| Q36063682 | Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3 |
| Q39445406 | Wnt signaling in cardiovascular disease: opportunities and challenges |
| Q90011343 | Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors |
| Q37539422 | Wnt signalling and cancer stem cells. |
| Q90419301 | Wnt/β-catenin in ischemic myocardium: interactions and signaling pathways as a therapeutic target |
| Q38874087 | Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration |
| Q38544289 | Wnt/β-catenin signaling in heart regeneration. |
| Q59790761 | Wnt/β-catenin-mediated signaling re-activates proliferation of matured cardiomyocytes |
| Q36144944 | Wnt10b Gain-of-Function Improves Cardiac Repair by Arteriole Formation and Attenuation of Fibrosis. |
| Q28573942 | miR-145 is differentially regulated by TGF-β1 and ischaemia and targets Disabled-2 expression and wnt/β-catenin activity |
| Q30581923 | sfrp1 promotes cardiomyocyte differentiation in Xenopus via negative-feedback regulation of Wnt signalling. |
Search more.